Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
This piece highlights safer starter options, basic risk controls, and practical tips to protect your early crypto portfolio.
19,284 articlesInvestors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
The record between corporate profits and worker pay has widened to a postwar high, signaling a troubling drift in the...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
Premium concert seats can test budgets, but smart planning makes live music affordable. This guide breaks down pricin...
The Nasdaq Composite kicks off June on a cautious note as oil spikes raise risk, while Nvidia powers the tech rally. ...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...
Visa and Mastercard trade near key price levels as investors reassess growth prospects, margins, and regulatory risk....
ONEOK posted robust Q4 2025 results, boosting full-year EBITDA, trimming debt, and highlighting synergies from recent...
AMC Networks reports Q1 2026 results that hinge on streaming momentum and disciplined costs. This piece breaks down t...
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Primerica's earnings trajectory hinges on policy sales, investment product performance, and agent distribution. This ...